However, whether this heterodimerization is functionally involved in cancer development and in the assembly of the NONO-STAT3-SFPQ-triple complex is still unclear however; it is therefore yet unknown whether disruption of either this heterodimer or complex will suppress NONO functions. The gene discussed is SFPQ; the disease is cancer.